It is important to see a provider/clinic that is well educated on weight loss as a whole, rather than simply prescribing medications, because long-term weight management requires diet, exercise, and lifestyle changes even alongside using weight loss medications
This timeline assumes Phase 3 trials complete in late 2026, FDA submission occurs in early 2027, and the review process takes 612 months
Arafat, A
New study links weight loss jabs to huge drop in alcohol-related hospital admissions The analysis found GLP-1 drugs slashed the risk of alcohol-related hospital admission by 26% compared with other diabetes medicines Bookmark CommentsGo to comments Weight loss drugs such like Wegovy and Mounjaro could be linked to a drop in the amount of people who are dependent on alcohol being admitted to hospital
Retatrutide goes further by engaging additional receptors, potentially offering broader effects for individuals dealing with metabolic challenges
Peer review Peer review information Nature Reviews Cancer thanks Dong Gao and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
